Widespread brain inflammation diminishes over time in Long COVID, shifting the clinical focus to emotional regulation.

Long COVID affects up to 18 million Americans, yet research funding remains inadequate. Experts call for aggressive NIH investment in novel treatments.

Some people who've suffered through COVID-19 never quite feel 100 percent, stuck in the throes of a medical mystery centered around an impaired immune system. Long COVID isn't fully understood yet, ...

Two Solve Catalyst Award-winning projects will expand whole-genome discovery and test a promising low-cost therapy targeting inflammation and energy dysfunction—key steps toward biomarkers and ...

Solve ME/CFS Initiative’s (Solve M.E.) Catalyst Awards provide targeted funding to help studies in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and related ...